Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma
Qibiao Wu(Broad Institute), Nabeel Bardeesy(Broad Institute)
Cited by 77
Related Papers
Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
|Nature|2015|788
<i>Smad4</i> is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
|Genes & Development|2006|652
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers
|Nature Cancer|2023|21
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
|Clinical Cancer Research|2024|14